UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy

The journal of clinical endocrinology and metabolism, 2011-11, Vol.96 (11), p.3381-3389

2011

Volltextzugriff (PDF)

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate

European journal of nuclear medicine and molecular imaging, 2003-03, Vol.30 (3), p.417-422

2003

Volltextzugriff (PDF)

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2013-05, Vol.40 (5), p.800-816

2013

Volltextzugriff (PDF)

Lutetium-labelled peptides for therapy of neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2012-02, Vol.39 (Suppl 1), p.103-112

2012

Volltextzugriff (PDF)

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors

European journal of nuclear medicine and molecular imaging, 2016-05, Vol.43 (5), p.839-851

2016

Volltextzugriff (PDF)

5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients

Bone (New York, N.Y.), 2012-06, Vol.50 (6), p.1260-1265

2012

Volltextzugriff (PDF)

Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy

Annals of oncology, 1999, Vol.10 (suppl-2), p.S23-S29

1999

Volltextzugriff (PDF)

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

European Journal of Nuclear Medicine, 1993-08, Vol.20 (8), p.716-731

1993

Volltextzugriff (PDF)

Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?

European journal of nuclear medicine and molecular imaging, 2006-11, Vol.33 (11), p.1346-1351

2006

Volltextzugriff (PDF)

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2014-03, Vol.41 (3), p.584-584

2014

Volltextzugriff (PDF)

Well-Differentiated Gastric Tumors/Carcinomas

Neuroendocrinology, 2006-01, Vol.84 (3), p.158-164

2006

Volltextzugriff (PDF)

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

European Journal of Nuclear Medicine, 2001-09, Vol.28 (9), p.1319-1325

2001

Volltextzugriff (PDF)

Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma

European Journal of Nuclear Medicine, 2000-09, Vol.27 (9), p.1312-1317

2000

Volltextzugriff (PDF)

Chromogranin A: its clinical value as marker of neuroendocrine tumours

European journal of clinical investigation, 1998-06, Vol.28 (6), p.431-440

1998

Volltextzugriff (PDF)

Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide

The Journal of nuclear medicine (1978), 1992-05, Vol.33 (5), p.652

1992

Volltextzugriff (PDF)

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre‐naive mature B lymphocytes

Clinical and experimental immunology, 2013-11, Vol.174 (2), p.256-264

2013

Volltextzugriff (PDF)

Evaluation of radiolabelled bombesin analogues for receptor‐targeted scintigraphy and radiotherapy

International journal of cancer, 1999-05, Vol.81 (4), p.658-665

1999

Volltextzugriff (PDF)

Somatostatin receptor: scintigraphy and radionuclide therapy

Digestion, 1996, Vol.57 Suppl 1 (1), p.57-61

1996

Volltextzugriff (PDF)

Somatostatin and the immune and haematopoetic system; a review

European journal of clinical investigation, 1994-02, Vol.24 (2), p.91-99

1994

Volltextzugriff (PDF)

Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro

The journal of clinical endocrinology and metabolism, 2000-04, Vol.85 (4), p.1719-1726

2000

Volltextzugriff (PDF)

Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status

European journal of nuclear medicine and molecular imaging, 2015-08, Vol.42 (9), p.1341-1352

2015

Volltextzugriff (PDF)

Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives

European Journal of Nuclear Medicine, 2001-09, Vol.28 (9), p.1421-1429

2001

Volltextzugriff (PDF)

Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma

European journal of endocrinology, 2000-11, Vol.143 (5), p.615-621

2000

Volltextzugriff (PDF)

Somatostatin receptor imaging in patients with sarcoidosis

European journal of nuclear medicine, 1998-09, Vol.25 (9), p.1284-1292

1998

Volltextzugriff (PDF)

Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer

Journal of endocrinological investigation, 2001-06, Vol.24 (6), p.415-422

2001

Volltextzugriff (PDF)

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(210)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(165)
Science & Technology
(160)
Life Sciences & Biomedicine
(159)
Biological And Medical Sciences
(90)
Medical Sciences
(83)
Female
(81)
Male
(78)
Middle Aged
(72)
Radionuclide Imaging
(55)
Aged
(54)
Endocrinology & Metabolism
(51)
Adult
(46)
Octreotide - Analogs & Derivatives
(44)
Radiology, Nuclear Medicine & Medical Imaging
(39)
Indium Radioisotopes
(37)
Receptors, Somatostatin - Analysis
(32)
Octreotide - Therapeutic Use
(30)
Pentetic Acid - Analogs & Derivatives
(27)
Somatostatin
(26)
Animals
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Lutetium-labelled peptides for therapy of neuroendocrine tumours

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors

5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients

Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Well-Differentiated Gastric Tumors/Carcinomas

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma

Chromogranin A: its clinical value as marker of neuroendocrine tumours

Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre‐naive mature B lymphocytes

Evaluation of radiolabelled bombesin analogues for receptor‐targeted scintigraphy and radiotherapy

Somatostatin receptor: scintigraphy and radionuclide therapy

Somatostatin and the immune and haematopoetic system; a review

Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro

Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status

Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives

Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma

Somatostatin receptor imaging in patients with sarcoidosis

Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer

Suchergebnisse filtern